Full-Time

Area BDR Manager

Northeast

Confirmed live in the last 24 hours

HeartFlow

HeartFlow

501-1,000 employees

Non-invasive cardiac testing technology provider

Healthcare

Compensation Overview

$140k - $180kAnnually

Senior

Boston, MA, USA + 1 more

More locations: New York, NY, USA

Covers the Northeast area.

Category
Business Development
Business & Strategy
Required Skills
Sales
Requirements
  • 4-year degree with 5+ years of related sales or clinical experience or 2-year degree with 7+ years related sales or clinical experience.
  • Degree in Science, Medical, Business, Marketing or Technical field is preferred.
  • Prior experience in medical device, cardiology pharmaceuticals, cardiology radio-pharmaceuticals, hospital, or medical software is highly desired.
  • Experience with introducing new cardiovascular technologies into hospitals is highly desired.
Responsibilities
  • Will work cross functionally to create solutions as new opportunities present.
  • Create progressive programming that disrupts the traditional means to reach ordering physicians who treat and manage patients with CAD.
  • Will work directly with key strategic HeartFlow accounts to drive growth and adoption of a cCTA and FFRct clinical pathway. In these accounts, the Area BDR Manager will develop and execute business development plans working closely with the account’s key stakeholders.
  • Facilitate cross-functional collaboration throughout the organization. Tools for program development could include key deployment of HeartFlow internal leadership and physician mentors, organizing and staffing of dinner programs, VIP Visits, organizing HeartFlow CT Pathway road-shows, referring physician office meetings, etc. This role will work closely with the other HeartFlow team members to include respective DSM, Marketing, Market Access, CT Apps, Product Development and Clinical.
  • Increase HeartFlow usage within the designated key strategic HeartFlow account by:
  • Maintaining and building relationships with referring physicians and other key clinical stakeholders
  • Educating customers on HeartFlow’s value proposition by giving presentations/ having discussions with referring MDs
  • Promoting / championing HeartFlow and building advocacy
  • Production/Success/Achievement of the Business Development Representative will be evaluated and based on performance in active/targeted accounts (metrics):
  • Meet / exceed quota for the strategic HeartFlow accounts (within existing customer locations).
  • cCTA growth (conversion of non-invasive tests) and FFRct penetration / case growth over baseline (% and $) in assigned accounts.

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company offers several analyses, including FFRCT Analysis and Plaque Analysis, which have received FDA clearance and are available in the U.S., U.K., Japan, and Canada. Unlike competitors, HeartFlow focuses on non-invasive solutions that enhance treatment planning. The goal is to improve cardiovascular care by making it safer and more efficient.

Company Stage

Series F

Total Funding

$858.5M

Headquarters

Redwood City, California

Founded

2010

Growth & Insights
Headcount

6 month growth

4%

1 year growth

16%

2 year growth

20%
Simplify Jobs

Simplify's Take

What believers are saying

  • The recent $215 million Series F funding round led by Bain Capital Life Sciences positions HeartFlow for significant growth and expansion.
  • HeartFlow's AI-enabled products, such as the RoadMap Analysis, enhance diagnostic accuracy and efficiency, potentially improving patient outcomes and physician workflows.
  • With coverage by 100% of Medicare and over 98% of commercial payers, HeartFlow's technology is widely accessible, increasing its adoption and market penetration.

What critics are saying

  • The cardiovascular care market is highly competitive, requiring continuous innovation to maintain a leading position.
  • Regulatory hurdles and the need for ongoing FDA clearances could delay product launches and market entry.

What makes HeartFlow unique

  • HeartFlow's non-invasive cardiac test offers a safer and more efficient alternative to traditional invasive procedures, setting it apart in the cardiovascular care market.
  • The company's comprehensive product portfolio, including FFRCT, RoadMap, and Plaque Analysis, provides a unique combination of anatomical and physiological visualization of coronary arteries.
  • HeartFlow's technology has received FDA clearance and is commercially available in multiple countries, ensuring a broad market reach and regulatory credibility.

Help us improve and share your feedback! Did you find this helpful?